Trial intelligence / Profile preview

Metformin and Growth Hormone in SGA Children

NCT02931591Unknown

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Start
Nov 2016
Primary completion
Nov 2019
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of liquid metformin (Aspargo Labs) in Small for gestational age (SGA) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Area under the curve of IGF-1 levels at 6 months. Status: unknown.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

Small for gestational age (SGA)

Beyond the preview

Go deeper on NCT02931591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02931591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call